| Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript |
Sotera Health Company (NASDAQ:SHC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras - Chairman, Chief Executive Officer Jonathan Lyons - Chief Financial Officer Jason Peterson - Vice President of Investor Relations and Treasurer Conference Call Participants Patrick Donnelly - Citi Brett Fishbin - KeyBanc Matt Sykes - Goldman Sachs Luke Sergott - Barclays Dave Windley - Jefferies Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning. And welcome to the Sotera Health First Quarter of 2025 Earnings Call. |
seekingalpha.com |
2025-05-02 18:37:10 |
Czytaj oryginał (ang.) |
| Sotera Health (SHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates |
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-05-01 14:35:46 |
Czytaj oryginał (ang.) |
| Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates |
Sotera Health Company (SHC) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago. |
zacks.com |
2025-05-01 13:55:40 |
Czytaj oryginał (ang.) |
| Sotera Health Reports First-Quarter 2025 Results |
CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2025. |
globenewswire.com |
2025-05-01 11:38:00 |
Czytaj oryginał (ang.) |
| Sotera Health Announces First-Quarter 2025 Earnings Release Date |
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's financial results and operating highlights. |
globenewswire.com |
2025-04-17 21:16:00 |
Czytaj oryginał (ang.) |
| Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock? |
Investors need to pay close attention to Sotera Health (SHC) stock based on the movements in the options market lately. |
zacks.com |
2025-04-14 15:10:48 |
Czytaj oryginał (ang.) |
| Sotera Health Has A Great Deleveraging Path Ahead |
Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention and long-term contracts. The company operates through Sterigenics, Nordion, and Nelson Labs, with a global network and leading market positions in sterilization services and Co-60 supply. Despite a 6% revenue decline in FY24 due to Nordion's lumpy revenue, Sotera maintains high adjusted EBITDA margins (~50%) and plans for CapEx reduction and debt deleveraging. |
seekingalpha.com |
2025-04-08 16:34:07 |
Czytaj oryginał (ang.) |
| Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results |
Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application |
globenewswire.com |
2025-03-04 09:00:00 |
Czytaj oryginał (ang.) |
| Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript |
Sotera Health Company (NASDAQ:SHC ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petras – Chairman and Chief Executive Officer Jon Lyons – Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Sean Dodge – RBC Capital Markets Luke Sergott – Barclays Casey Woodring – J.P. Morgan Brett Fishbin – KeyBanc Dave Windley – Jefferies Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call. |
seekingalpha.com |
2025-02-27 16:15:46 |
Czytaj oryginał (ang.) |
| Compared to Estimates, Sotera Health (SHC) Q4 Earnings: A Look at Key Metrics |
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-02-27 12:36:15 |
Czytaj oryginał (ang.) |
| Sotera Health Company (SHC) Meets Q4 Earnings Estimates |
Sotera Health Company (SHC) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.26 per share a year ago. |
zacks.com |
2025-02-27 11:40:26 |
Czytaj oryginał (ang.) |
| Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook |
CLEVELAND, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the fourth-quarter and full-year 2024 and its initial 2025 outlook. |
globenewswire.com |
2025-02-27 09:00:00 |
Czytaj oryginał (ang.) |
| Insights Into Sotera Health (SHC) Q4: Wall Street Projections for Key Metrics |
Evaluate the expected performance of Sotera Health (SHC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. |
zacks.com |
2025-02-24 12:22:06 |
Czytaj oryginał (ang.) |
| Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date |
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2024 before the market opens on Thursday, February 27, 2025. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results. |
globenewswire.com |
2025-02-18 18:30:00 |
Czytaj oryginał (ang.) |
| Sotera Health Chairman and CEO Presents at 43rd Annual J.P. Morgan Healthcare Conference |
CLEVELAND, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health's business. |
globenewswire.com |
2025-01-14 09:30:00 |
Czytaj oryginał (ang.) |
| Sotera Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 11:15 a.m. Eastern Time. Mr. Petras, Jon Lyons, Senior Vice President and CFO, and Jason Peterson, Vice President, Investor Relations and Treasurer, will participate in meetings with investors during the conference. |
globenewswire.com |
2025-01-07 18:30:00 |
Czytaj oryginał (ang.) |
| Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director |
CLEVELAND, Ohio, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is pleased to announce today the appointment of Vincent K. Petrella as Lead Independent Director, effective January 2, 2025. |
globenewswire.com |
2025-01-06 18:30:00 |
Czytaj oryginał (ang.) |
| Firstlight Management Calls on the Board of Directors of Sotera Health Company to Launch Sale Process for Nelson Labs |
NEW YORK , Dec. 18, 2024 /PRNewswire/ -- On December 3, 2024, Firstlight Management LP sent a letter to the Board of Directors of Sotera Health Company (NASDAQ: SHC) calling for a sale of its Nelson Labs subsidiary. The full text of the letter is as follows: Dear Members of the Board, As you know, Firstlight Management is a Utah-based investment firm founded by an alumnus of Tiger Management and Leonard Green & Partners. |
prnewswire.com |
2024-12-18 09:00:00 |
Czytaj oryginał (ang.) |
| Sotera Health to Share Next Chapter of Growth at 2024 Investor Day |
CLEVELAND, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, will hold an Investor Day in New York City where Sotera Health's management team will discuss the Company's strategic positioning and outline future growth plans. Management will take questions from a live audience during two question-and-answer sessions. |
globenewswire.com |
2024-11-20 11:00:00 |
Czytaj oryginał (ang.) |
| Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript |
Sotera Health Company (NASDAQ:SHC ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Sean Dodge - RBC Capital Markets Patrick Donnelly - Citigroup Inc. Salem Salem - Barclays Brett Fishbin - KeyBanc Capital Markets Casey Woodring - J.P. Morgan Chase Jason Bednar - Piper Sandler Dave Windley - Jefferies Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health Third Quarter 2024 Conference Call. |
seekingalpha.com |
2024-11-05 19:04:34 |
Czytaj oryginał (ang.) |
| Sotera Health (SHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates |
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2024-11-05 13:01:34 |
Czytaj oryginał (ang.) |
| Sotera Health Company (SHC) Q3 Earnings Lag Estimates |
Sotera Health Company (SHC) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.21 per share a year ago. |
zacks.com |
2024-11-05 11:25:23 |
Czytaj oryginał (ang.) |
| Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results |
CLEVELAND, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three and nine months ended September 30, 2024. |
globenewswire.com |
2024-11-05 09:00:00 |
Czytaj oryginał (ang.) |
| Analysts Estimate Sotera Health Company (SHC) to Report a Decline in Earnings: What to Look Out for |
Sotera Health (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2024-10-29 13:06:47 |
Czytaj oryginał (ang.) |
| Sotera Health Announces Dates for Third-Quarter 2024 Earnings Release and November 2024 Investor Day |
CLEVELAND, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third-quarter ended September 30, 2024 before the market opens on Tuesday, November 5, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results. |
globenewswire.com |
2024-10-22 20:30:00 |
Czytaj oryginał (ang.) |
| Sotera Health Announces Secondary Offering of Common Stock |
CLEVELAND, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. It is expected that, as a result of the Offering, the Company's sponsors (affiliates of Warburg Pincus and GTCR) will cease to own a majority of the Company's outstanding common stock, which will affect certain sponsor rights and related matters. These rights are described in the Company's most recently filed annual general meeting proxy statement. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Registration Rights Agreement. |
globenewswire.com |
2024-09-04 20:41:00 |
Czytaj oryginał (ang.) |
| Sotera Health Company (SHC) Q2 2024 Earnings Call Transcript |
Sotera Health Company (NASDAQ:SHC ) Q2 2024 Earnings Conference Call August 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Dave Windley - Jefferies Brett Fishbin - KeyBanc Capital Markets Patrick Donnelly - Citigroup Inc. Casey Woodring - J.P. Morgan Chase Salem Salem - Barclays Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health Second Quarter 2024 Conference Call. |
seekingalpha.com |
2024-08-05 18:44:07 |
Czytaj oryginał (ang.) |
| Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics |
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2024-08-05 14:30:58 |
Czytaj oryginał (ang.) |
| Sotera Health Company (SHC) Q2 Earnings and Revenues Surpass Estimates |
Sotera Health Company (SHC) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.21 per share a year ago. |
zacks.com |
2024-08-05 13:16:14 |
Czytaj oryginał (ang.) |
| Sotera Health Reports Second-Quarter and First-Half 2024 Results |
CLEVELAND, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three and six months ended June 30, 2024. |
globenewswire.com |
2024-08-05 11:00:00 |
Czytaj oryginał (ang.) |
| Sotera Health Appoints Christopher Simon to the Board of Directors |
CLEVELAND, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Christopher Simon as a new independent director to its Board of Directors. Mr. Simon will serve as a member of the Leadership Development and Compensation Committee of the Board of Directors. |
globenewswire.com |
2024-08-01 11:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Urges Sotera Health Company Investors With Losses Over $100,000 To Establish Communication |
LOS ANGELES, CA / ACCESSWIRE / July 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023. |
accesswire.com |
2024-07-30 13:45:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Urges Sotera Health Company Investors With Losses Over $100,000 To Establish Communication |
LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023. |
accesswire.com |
2024-07-30 03:30:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Establish Communication |
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023. |
accesswire.com |
2024-07-26 20:30:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Establish Communication |
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023. |
accesswire.com |
2024-07-25 20:30:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Establish Communication |
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023. |
accesswire.com |
2024-07-25 00:15:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Establish Communication |
LOS ANGELES, CA / ACCESSWIRE / July 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023. |
accesswire.com |
2024-07-23 22:30:00 |
Czytaj oryginał (ang.) |